Measurement of urinary excretion of nonisomerized and ?-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease
Year: 1998
Type: article
Source: Arthritis & Rheumatism
Authors: Patrick Garnero, Evelyne Gineyts, A. Victoria Schaffer, John Seaman, Pierre D. Delmas
Institutions: Inserm, Novartis (United States)
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2072385122
